trimethoprim has been researched along with Colorectal Cancer in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamiyama, S | 1 |
Ichimiya, T | 1 |
Ikehara, Y | 1 |
Takase, T | 1 |
Fujimoto, I | 1 |
Suda, T | 1 |
Nakamori, S | 1 |
Nakamura, M | 1 |
Nakayama, F | 1 |
Irimura, T | 1 |
Nakanishi, H | 1 |
Watanabe, M | 1 |
Narimatsu, H | 1 |
Nishihara, S | 1 |
1 other study available for trimethoprim and Colorectal Cancer
Article | Year |
---|---|
Expression and the role of 3'-phosphoadenosine 5'-phosphosulfate transporters in human colorectal carcinoma.
Topics: Anion Transport Proteins; Biological Transport; Cell Proliferation; Colorectal Neoplasms; Drug Combi | 2011 |